Epidemiology and Public Health, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Health Statistics Research Group, Institute of Health Research, University of Exeter Medical School, St Luke's Campus, Exeter, United Kingdom.
JAMA Intern Med. 2018 Jan 1;178(1):93-99. doi: 10.1001/jamainternmed.2017.7023.
There is mixed evidence that blood pressure (BP) stabilizes or decreases in later life. It is also unclear whether BP trajectories reflect advancing age, proximity to end of life, or selective survival of persons free from hypertension.
To estimate individual patient BP for each of the 20 years before death and identify potential mechanisms that may explain trajectories.
DESIGN, STUDY, AND PARTICIPANTS: We analyzed population-based Clinical Practice Research Datalink primary care and linked hospitalization electronic medical records from the United Kingdom, using retrospective cohort approaches with generalized linear mixed-effects modeling. Participants were all available individuals with BP measures over 20 years, yielding 46 634 participants dying aged at least 60 years, from 2010 to 2014. We also compared BP slopes from 10 to 3 years before death for 20 207 participants who died, plus 20 207 birth-year and sex-matched participants surviving longer than 9 years.
Clinically recorded individual patient repeated systolic BP (SBP) and diastolic BP (DBP).
In 46 634 participants (51.7% female; mean [SD] age at death, 82.4 [9.0] years), SBPs and DBPs peaked 18 to 14 years before death and then decreased progressively. Mean changes in SBP from peak values ranged from -8.5 mm Hg (95% CI, -9.4 to -7.7) for those dying aged 60 to 69 years to -22.0 mm Hg (95% CI, -22.6 to -21.4) for those dying at 90 years or older; overall, 64.0% of individuals had SBP changes of greater than -10 mm Hg. Decreases in BP appeared linear from 10 to 3 years before death, with steeper decreases in the last 2 years of life. Decreases in SBP from 10 to 3 years before death were present in individuals not treated with antihypertensive medications, but mean yearly changes were steepest in patients with hypertension (-1.58; 95% CI, -1.56 to -1.60 mm Hg vs -0.70; 95% CI, -0.65 to -0.76 mm Hg), dementia (-1.81; 95% CI, -1.77 to -1.87 mm Hg vs -1.41; 95% CI, -1.38 to -1.43 mm Hg), heart failure (-1.66; 95% CI, -1.62 to -1.69 mm Hg vs -1.37; 95% CI, -1.34 to -1.39 mm Hg), and late-life weight loss.
Mean SBP and DBP decreased for more than a decade before death in patients dying at 60 years and older. These BP decreases are not simply attributable to age, treatment of hypertension, or better survival without hypertension. Late-life BP decreases may have implications for risk estimation, treatment monitoring, and trial design.
有混合证据表明,血压(BP)在晚年趋于稳定或降低。也不清楚 BP 轨迹是否反映了年龄的增长、接近生命终点,还是高血压患者以外的人的选择性存活。
估计每位患者在死亡前 20 年的个体 BP,并确定可能解释轨迹的潜在机制。
设计、研究和参与者:我们分析了来自英国的基于人群的临床实践研究数据链接初级保健和相关住院电子病历,使用了回顾性队列方法和广义线性混合效应建模。参与者均为在 20 年内有 BP 测量值的个体,共有 46634 名年龄至少 60 岁的参与者死亡,死亡时间为 2010 年至 2014 年。我们还比较了 20207 名死亡参与者和 20207 名出生年份和性别匹配的、存活时间超过 9 年的参与者在死亡前 10 年至 3 年的 BP 斜率。
临床记录的个体患者重复收缩压(SBP)和舒张压(DBP)。
在 46634 名参与者中(51.7%为女性;死亡时的平均[SD]年龄为 82.4[9.0]岁),SBP 和 DBP 在死亡前 18 至 14 年达到峰值,然后逐渐下降。从峰值到死亡时 SBP 的平均变化范围从 60 至 69 岁死亡的个体中的-8.5mmHg(95%CI,-9.4 至-7.7mmHg)到 90 岁或以上死亡的个体中的-22.0mmHg(95%CI,-22.6 至-21.4mmHg);总体而言,64.0%的个体 SBP 变化大于-10mmHg。从死亡前 10 年到 3 年,BP 下降呈线性趋势,在生命的最后 2 年下降更为陡峭。在未接受降压药物治疗的个体中,从死亡前 10 年到 3 年的 SBP 下降,但在高血压(-1.58;95%CI,-1.56 至-1.60mmHg vs -0.70;95%CI,-0.65 至-0.76mmHg)、痴呆(-1.81;95%CI,-1.77 至-1.87mmHg vs -1.41;95%CI,-1.38 至-1.43mmHg)、心力衰竭(-1.66;95%CI,-1.62 至-1.69mmHg vs -1.37;95%CI,-1.34 至-1.39mmHg)和晚期体重减轻的患者中,平均每年 SBP 变化最大。
在 60 岁及以上死亡的患者中,SBP 和 DBP 在死亡前超过 10 年的时间内下降。这些 BP 下降不仅仅是由于年龄、高血压治疗或没有高血压的更好生存。晚期 BP 下降可能对风险估计、治疗监测和试验设计有影响。